Cannabis company Curaleaf draws downgrade to hold at Benchmark, while Wedbush sticks to outperform
May 19, 2023 at 08:44 AM EDT
Benchmark flags cannabis market "uncertainty" while Wedbush sees "good start" to 2023 after Curaleaf beats revenue target, posts narrower-than-expected loss.
